Author Question: Bald cypress and loblolly pine are both gymnosperm trees native to the southern (Read 897 times)

xclash

  • Hero Member
  • *****
  • Posts: 681
Bald cypress and loblolly pine are both gymnosperm trees native to the southern United States. The cypress grows in swamps; the pine grows in sandy soil. How do you think their anatomies differ?
A) There are larger intercellular spaces in the roots of the cypress than in the roots of the pine.
B) Water-conducting cells are larger in the stems of the cypress than in the stems of the pine.
C) The springwood and summerwood are more distinct in the cypress.
D) There is less parenchyma in the roots of the cypress than in the pine roots.
E) There are no major anatomical differences between these species because they're both gymnosperms.



clippers!

  • Hero Member
  • *****
  • Posts: 828
I chose A and got the answer, hope that helps.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library